Relenza anti-influenza (flu) drug and inhaler

Relenza anti-influenza (flu) drug and inhaler

M726/0014 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 51.1MB

Downloadable file size: 2.7MB

Price image Pricing

Please login to use the price calculator


Caption: Relenza anti-flu drug. Opened pack of the anti- influenza (flu) drug preparation Relenza. The blister packs contain the powdered drug that is taken using the inhaler. If treatment begins within two days of the onset of flu symptoms, this drug can reduce their duration by up to 36 hours. However, Relenza cannot prevent influenza infections. Relenza contains the drug zanamivir which inhibits the neuraminidase enzyme which influenza viruses use to break away from one infected cell in order to infect other healthy cells.

Release details: Model release not required. Property release not required.

Keywords: anti-influenza, anti-influenza drug, drug, drug take, flu, healthcare, influenza, inhaler, medical, medicate, medication, medicine, neuraminidase inhibitor, relenza, taking, treatment, zanamivir

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.